BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2021 2:14:13 PM | Browse: 467 | Download: 1567
 |
Received |
|
2021-01-20 04:57 |
|
Peer-Review Started |
|
2021-01-20 04:58 |
|
First Decision by Editorial Office Director |
|
2021-09-28 04:04 |
|
Return for Revision |
|
2021-09-28 04:04 |
|
Revised |
|
2021-10-15 16:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-11-02 03:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-11-03 01:19 |
|
Articles in Press |
|
2021-11-03 01:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-03 09:55 |
|
Publish the Manuscript Online |
|
2021-12-23 14:14 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cheng Pang, Miao Wang, Hui-Min Hou, Jian-Yong Liu, Zhi-Peng Zhang, Xuan Wang, Ya-Qun Zhang, Chun-Mei Li, Wei Zhang, Jian-Ye Wang and Ming Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Hospital Clinical Research 121 Project |
BJ-2018-090 |
|
| Corresponding Author |
Ming Liu, MD, Chief Doctor, Professor, Surgeon, Surgical Oncologist, Department of Urology, Beijing Hospital, No. 1 Dahua Road, Dongdan, Dongcheng District, Beijing 100730, China. liumingbjh@126.com |
| Key Words |
Prostate neoplasms; Magnetic resonance imaging; Cognitive fusion; Prostate biopsy; Prostate cancer |
| Core Tip |
Prostate biopsy remains the standard diagnostic modality before curative treatment. Cognitive magnetic resonance imaging (MRI)-ultrasound fusion biopsy is a more accessible and economical biopsy technique for small-sample institutions to realize imaging-guided targeted biopsy. In this study, we proposed a customized template and reported a feasible approach for cognitive MRI-ultrasound fusion biopsy with our single institutional experience. The results from this retrospective study revealed that a high yield of cancer, and that patients with higher prostate-specific antigen density and Prostate Imaging-Reporting and Data System scores are more likely to be diagnosed with prostate cancer under this biopsy strategy. |
| Publish Date |
2021-12-23 14:14 |
| Citation |
Pang C, Wang M, Hou H, Liu JY, Zhang Z, Wang X, Zhang Y, Li C, Zhang W, Wang J, Liu M. Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer. World J Clin Cases 2021; 9(36): 11183-11192 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i36/11183.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i36.11183 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
